INOVIO to Report Second Quarter Financial Results on August 12, 2026
Rhea-AI Summary
INOVIO (NASDAQ: INO) will release its second quarter 2026 financial results after the market close on August 12, 2026. The company will host a live, listen-only conference call and webcast at 4:30 p.m. ET to review the results and provide a general business update. The webcast, including a live Q&A with analysts, will be accessible via INOVIO's investor relations website and will remain available as an archived replay for 90 days.
Positive
- None.
Negative
- None.
AI-generated analysis. How Rhea-AI works. Not financial advice.
The live webcast will be available online at http://ir.inovio.com/events-and-presentations/default.aspx. This is a listen-only event but will include a live Q&A with analysts. The webcast will be archived and available for replay for 90 days following the event.
About INOVIO
INOVIO is a biotechnology company focused on developing and commercializing innovative DNA medicines to help treat and protect people from HPV-related diseases, cancer, and infectious diseases. INOVIO's technology optimizes the design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. For more information, visit www.inovio.com
Contacts
Media: Jennie Willson, (267) 429-8567, communications@inovio.com
Investors: Peter Vozzo - ICR Healthcare, (443) 213-0505, investor.relations@inovio.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/inovio-to-report-second-quarter-financial-results-on-august-12-2026-302842917.html
SOURCE INOVIO Pharmaceuticals, Inc.